Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr;8(4):271-272.
doi: 10.1016/S2213-8587(20)30071-1.

BPA and risk assessment - Authors' reply

Patricia A Hunt  1 , Frederick S Vom Saal  2 , Richard Stahlhut  3 , Roy Gerona  4
Affiliations
Comment

BPA and risk assessment - Authors' reply

Patricia A Hunt et al. Lancet Diabetes Endocrinol. 2020 Apr.
No abstract available

PubMed Disclaimer

Comment on

  • BPA: have flawed analytical techniques compromised risk assessments?
    Gerona R, Vom Saal FS, Hunt PA. Gerona R, et al. Lancet Diabetes Endocrinol. 2020 Jan;8(1):11-13. doi: 10.1016/S2213-8587(19)30381-X. Epub 2019 Dec 5. Lancet Diabetes Endocrinol. 2020. PMID: 31813841 No abstract available.
  • BPA and risk assessment.
    Calafat AM, Koch HM; additional coauthors. Calafat AM, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):269-270. doi: 10.1016/S2213-8587(20)30070-X. Lancet Diabetes Endocrinol. 2020. PMID: 32197109 Free PMC article. No abstract available.
  • BPA and risk assessment.
    Palmer K, Speirs V. Palmer K, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):269. doi: 10.1016/S2213-8587(20)30068-1. Lancet Diabetes Endocrinol. 2020. PMID: 32197110 No abstract available.
  • BPA and risk assessment.
    Dupuis A, Rabouan S, Migeot V, Venisse N. Dupuis A, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):270-271. doi: 10.1016/S2213-8587(20)30069-3. Lancet Diabetes Endocrinol. 2020. PMID: 32197111 No abstract available.

LinkOut - more resources